4 Sc AG Stock Deutsche Boerse AG
Equities
DE0005753818
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- EUR | - |
Sales 2022 | 436K 474K 645K | Sales 2023 | 304K 330K 450K | Capitalization | 89.51M 97.27M 132M |
---|---|---|---|---|---|
Net income 2022 | -14M -15.21M -20.7M | Net income 2023 | -8M -8.69M -11.83M | EV / Sales 2022 | -4.31 x |
Net cash position 2022 | 14.82M 16.11M 21.92M | Net cash position 2023 | 5.22M 5.67M 7.72M | EV / Sales 2023 | 277 x |
P/E ratio 2022 |
-0.9
x | P/E ratio 2023 |
-10.9
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 26.68% |
1st Jan change | Capi. | |
---|---|---|
+9.42% | 115B | |
+11.84% | 106B | |
-14.15% | 21.84B | |
-1.05% | 21.96B | |
-5.29% | 19.21B | |
-38.29% | 17.71B | |
-4.16% | 18.08B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |